Type 2 diabetes and risk of non-Hodgkin lymphoma and multiple myeloma: a pooled analysis
Our findings suggest a role for T2D in DLBCL and MM; thus, T2D prevention may be important in reducing their incidence. Some unexpected inverse associations require further investigation.
Authors
- Chun Chao (ORCID: https://orcid.org/0000-0002-6072-4954)
- Emily L. Deubler (ORCID: https://orcid.org/0000-0003-4511-1452)
- Charlie Zhong (ORCID: https://orcid.org/0000-0001-6973-887X)
- Sophia S. Wang
- B. A. Rosner
- Kimberly A Bertrand
- Alpa V Patel
- Andres V Ardisson Korat
Institutions
- Boston University (US)
- Tufts University (US)
- Brigham and Women's Hospital (US)
- American Cancer Society (US)
- City Of Hope National Medical Center (US)
- Kaiser Permanente (US)
- Harvard University (US)
- City of Hope (US)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1093/jncics/pkag017
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00